Podcasts about fashp

In this episode of the Society of Critical Care Medicine (SCCM) Podcast, Diane C. McLaughlin, DNP, AGACNP-BC, CCRN, FNCS, FCCM, is joined by Aarti Sarwal, MD, FAAN, FNCS, RPNI, FCCM, and Brian L. Erstad, PharmD, FCCP, FASHP, MCCM, to discuss the 2026 guidelines for neuromuscular blockade in adult patients with acute respiratory distress syndrome. The guidelines, “Society of Critical Care Medicine Guidelines for the Administration of Neuromuscular Blockade in Adults With Acute Respiratory Distress Syndrome,” were published in the March issue of Critical Care Medicine. Drs. Sarwal and Erstad discuss how the evidence in two key trials, ACURASYS and PETAL-ROSE, has helped shape the recommendations provided in the SCCM guidelines. Despite how influential these trials were in shaping the recommendations, only conditional recommendations were made due to low or very low quality of evidence. The lack of evidence proved to be a driving factor in including a call to action in the guidelines. Future research priorities largely revolve around precision medicine and finding more patient-specific interventions to improve patient outcomes. Aarti Sarwal, MD, FAAN, FNCS, RPNI, FCCM, is a professor of neurology and the division chair of neurocritical care at Virginia Commonwealth University (VCU) School of Medicine in Richmond, Virginia, USA. She is also an associate editor of Critical Care Medicine, secretary of the American Society of Neuroimaging, and director of VCU-Wake Forest neuro-ultrasound courses. Brian L. Erstad, PharmD, FCCP, FASHP, MCCM, is a tenured professor and interim dean at the University of Arizona R. Ken Coit College of Pharmacy in Tucson, Arizona, USA. He is also a center investigator for the Center for Health Outcomes, a member of the BIO5 Institute and Comprehensive Center for Pain & Addiction and Pharmacoeconomics Research Center, and a codirector for the Arizona Clinical and Translational Research Graduate Certificate Program. Resources referenced in this podcast: Society of Critical Care Medicine Guidelines for the Administration of Neuromuscular Blockade in Adults With Acute Respiratory Distress Syndrome Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome Neuromuscular Blockers in Early Acute Respiratory Distress Syndrome

Kate Schaafsma, PharmD, MS, MBA, FASHP is the Vice President and Chief Pharmacy Officer at Rush University System for Health. Dr. Schaafsma started over a year ago in her role and we talk through the onboarding of a Chief Pharmacy Officer as well as her first year in the role! 

In this episode, Scott Knoer, PharmD, MS, FASHP, Regional Chief Pharmacy Officer, shares how he is transforming pharmacy at MercyOne by building ambulatory and specialty infrastructure, strengthening leadership teams, and driving improvement in both outcomes and the system's bottom line.

In this episode, Todd Karpinski, PharmD, MS, FASHP, FACHE, System Vice President and Chief Pharmacy Officer at WVU Medicine, joins the podcast to discuss the evolving pharmacy landscape. He shares perspectives on ongoing challenges with retail pharmacy reimbursements, addressing staffing shortages, and how strategic partnerships can support sustainable growth and strengthen pharmacy operations across the health system.

In this episode, Michael Evans, RPh, MBA, FASHP, Chief Pharmacy Officer for Enterprise Pharmacy at Geisinger, discusses key pharmacy priorities including biosimilar adoption, the impact of the Inflation Reduction Act, cell and gene therapy readiness, and strategies to expand access and strengthen pharmacy operations.

In this episode, Michael Evans, RPh, MBA, FASHP, Chief Pharmacy Officer for Enterprise Pharmacy at Geisinger, discusses key pharmacy priorities including biosimilar adoption, the impact of the Inflation Reduction Act, cell and gene therapy readiness, and strategies to expand access and strengthen pharmacy operations.

In this episode, Kuldip R. Patel, PharmD, FASHP, Senior Associate Chief Pharmacy Officer at Duke University Health System, discusses how pharmacy services are expanding across the continuum to reach more patients and improve outcomes. He shares insights on supply chain resilience, ambulatory and inpatient pharmacy growth, and the technologies shaping the future of pharmacy practice.

Melanie Dodd, PharmD, PhC, BCPS, FASHP, is the current President of the American Society of Health-System Pharmacists (ASHP) and the Associate Dean for Clinical Affairs and Professor at the University of New Mexico College of Pharmacy. Dr. Dodd talks through her priorities for ASHP this year, her involvement in the progressive New Mexico Society of Health-System Pharmacists, and her advice to those looking to get involved!

ASHP's senior education director, Cindy Von Heeringen is joined by William Dager, pharmacist specialist (Ret.) at University of California, Davis Medical Center, as he discusses his upcoming Midyear session that focuses on anticoagulation management plans in complex patients. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

During our conversation, Anthony Morreale, PharmD shares lessons from his remarkable 40-year career in pharmacy, including decades of leadership with the U.S. Department of Veterans Affairs. Dr. Morreale reflects on how curiosity, flexibility, and teamwork helped him identify and fill healthcare gaps, launch clinical pharmacy programs, and mentor future leaders. He discusses the growing importance of informatics, data-driven decision-making, and advanced therapeutics in shaping the future of pharmacy. Now a consultant and expert witness, Dr. Morreale continues to "fix gaps" by applying clinical insight to complex medical-legal cases. His story offers inspiration and practical wisdom for pharmacists at every career stage.   To learn more about Dr. Morreale, visit www.morrealeconsulting.com or connect on LinkedIn: https://www.linkedin.com/in/anthony-morreale-b8753635/    Special thanks to Dr. Pam Schweitzer for nominating Dr. Anthony Morreale as a guest.   Bio (October 2025) - Anthony P. Morreale, PharmD., MBA, BCPS, FASHP, CPEL   Dr. Morreale has demonstrated his professionalism and expertise as a clinician, manager and leader in pharmacy since his pharmacy career began in 1983. He has over 20 years of direct patient care experience as a clinical pharmacist in both acute and ambulatory care. In addition, he has decades of experience as a pharmacy manager, leader and executive. Dr. Morreale is board certified in pharmacotherapy and has been recognized by the American Society of Health System Pharmacists as a Certified Pharmacy Executive Leader. Dr. Morreale has been engaged as a business consultant, quality reviewer for standards of practice, and has served as an expert in medical legal cases. Dr. Morreale has expert knowledge and experience in nearly all areas of pharmacy practice including but not limited to:   •  Regulatory, operational and clinical pharmacy standards of practice for large health systems. •  Drug absorption, metabolism, excretion, outcomes, and adverse effects of both pharmaceuticals and street drugs. •  Application of patient genomics to therapeutic response and toxicities of various medications.   Dr. Morreale retired in October 2024 from his role as Associate Chief Consultant for Clinical Pharmacy Services and Policy for the Department of Veterans Affairs (VA) Pharmacy Benefits Management (PBM) in VA Central Office, where he oversaw national clinical pharmacy services, policy development, pay, recruitment, retention and legislation. He also has significant experience in Health Outcomes Research. Dr. Morreale is a highly experienced speaker both nationally and internationally and is very comfortable delivering understandable and succinct messages to various audiences. Dr. Morreale has authored or co-authored over 90 articles, has served on editorial boards, and as a reviewer on a number of professional journals.  He has been actively involved in leadership roles within many pharmacy organizations both nationally and internationally.   Dr. Morreale is the recipient of numerous awards including- ASHP Best Practice Award, ASHP Literature award for innovation, VA Under-Secretary's Innovation Award, JMCP Quality Reviewer Award for Accuracy, San Diego Society Pharmacist of the Year, California Michelotti Public Health Prize, the AMCP Avey Award, and most recently the APhA Distinguished Federal Pharmacist Award in 2018, and the ASHP Award for Excellence in 2020 and the ASHP Best Practice Award 2024.    Links from this episode Dr. Morreale's Website www.morrealeconsulting.com  Dr. Morreale on LinkedIn https://www.linkedin.com/in/anthony-morreale-b8753635/ U.S. Department of Veterans Affairs https://www.va.gov/ The Pharmacist's Voice Podcast Episode 185 featuring RDML Pam Schweitzer The Pharmacist's Voice Podcast Episode 229 featuring RDML Pam Schweitzer The Pharmacist's Voice Podcast Episode 251 featuring RDML Pam Schweitzer The Pharmacist's Voice Podcast Episode 133 featuring Dan Krinsky, RPh   Kim's websites and social media links: ✅ Monthly email newsletter sign-up link https://bit.ly/3AHJIaF  ✅ LinkedIn Newsletter link https://bit.ly/40VmV5B ✅ Audiobook Narration Services https://www.kimnewlove.com/narration  ✅ Business website https://www.thepharmacistsvoice.com ✅ Buy my book on amazon.com https://amzn.to/4iAKNBs  ✅ The Pharmacist's Voice ® Podcast https://www.thepharmacistsvoice.com/podcast ✅ Drug pronunciation course https://www.kimnewlove.com ✅ Podcasting Course https://www.kimnewlove.com/podcasting   ✅ LinkedIn https://www.linkedin.com/in/kimnewlove ✅ Facebook https://www.facebook.com/kim.newlove.96 ✅ Twitter https://twitter.com/KimNewloveVO ✅ Instagram https://www.instagram.com/kimnewlovevo/ ✅ YouTube https://www.youtube.com/channel/UCA3UyhNBi9CCqIMP8t1wRZQ ✅ ACX (Audiobook Narrator Profile) https://www.acx.com/narrator?p=A10FSORRTANJ4Z If you know someone who would like this episode, please share it with them. Subscribe for all future episodes. This podcast is on all major podcast players and YouTube. Popular links are below. ⬇️   Apple Podcasts   https://apple.co/42yqXOG  Spotify  https://spoti.fi/3qAk3uY  Amazon/Audible  https://adbl.co/43tM45P YouTube https://bit.ly/43Rnrjt   ⭐️ Sign up for The Pharmacist's Voice ® monthly email newsletter! https://bit.ly/3AHJIaF   Host Background: Kim Newlove has been an Ohio pharmacist since 2001 (BS Pharm, Chem Minor). Her experience includes hospital, retail, compounding, and behavioral health. She is also an author, voice actor (medical narrator and audiobook narrator), podcast host, and consultant (audio production and podcasting).   Thank you for listening to episode 355 of The Pharmacist's Voice ® Podcast.  If you know someone who would like this episode, please share it with them!

ASHP's education director, Hannah Post is joined by Angela Cassano, president of Pharmfusion Consulting, LLC, William Hammonds, clinical pharmacy manager at West Virginia University Medicine, and Carrington Huneycutt, director of clinical pharmacy at Tandem Health, South Carolina, as they discuss their upcoming Midyear session that focuses on implementation and evolution of clinical pharmacy technician roles.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

ASHP's senior education director, Cindy Von Heeringen is joined by James Hoffman, senior vice president of quality and safety, member, pharmacy and pharmaceutical sciences at St. Jude Children's Research Hospital, and Joe DiPiro, professor emeritus at Virginia Commonwealth University, School of Pharmacy, as they discuss their upcoming Midyear session that focuses on relevant trends in the external environment that will have a major impact on health-system pharmacy practice over the next five years.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

ASHP's senior education director, Cindy von Heeringen is joined by Mitchell Buckley, clinical pharmacy specialist at Buckley Group Enterprises LLC, as he discusses his upcoming Midyear sessions that focus on acute care clinical pharmacy performance metrics and the unique pharmacokinetic and pharmacodynamic challenges in dosing chemotherapy, anticoagulants, and antimicrobials for obese and underweight patients.   The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Stephen Eckel, PharmD, MHA, FAPhA, FASHP, FCCP, is the Associate Dean for Global Engagement and an Associate Professor at the UNC Eshelman School of Pharmacy. He is the Residency Program Director for the Health System Pharmacy Administration and Leadership Residency at UNC Medical Center (he was also my RPD!). Dr. Eckel is also the co-founder of ChemoGlo and founder of Assure Medical Technologies, LLC. We talk through leadership training and his involvement in FIP and global pharmacy practice. In addition, he has a passion for entrepreneurship and we talk through how he has identified business opportunities and has created successful companies from them. It's a jam packed episode and one you don't want to miss!

Listen in as our expert panel discusses the latest recommendations for managing medications after heart attacks and other cardiac events. You'll hear our panelists review which antiplatelets to use, the optimal blood pressure meds, and the role of statin and non-statin cholesterol meds.Special guests:Danielle Blais, PharmD, FCCP, BCCP, BCPSCardiology Lead Specialty Practice PharmacistRichard M. Ross Heart HospitalThe Ohio State University Wexner Medical CenterJoel C. Marrs, PharmD, MPH., BCACP, BCCP, BCPS, FAHA, FASHP, FCCP, FNLAProfessor and Coordinator of Clinical OutreachThe University of Tennessee Health Science CenterDepartment of Clinical Pharmacy & Translational ScienceYou'll also hear practical advice from panelists on TRC's Editorial Advisory Board:Andrea Darby-Stewart, MDAssociate Director, Honor Health Family Medicine Residency ProgramClinical Professor of Family, Community & Occupational MedicineThe University of Arizona College of Medicine – PhoenixCraig D. Williams, PharmD, FNLA, BCPSClinical Professor of Pharmacy PracticeOregon Health and Science UniversityNone of the speakers have anything to disclose. This podcast is an excerpt from one of TRC's monthly live CE webinars, the full webinar originally aired in July 2025.TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist's Letter, Pharmacy Technician's Letter, or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.Claim CreditThe clinical resources mentioned are part of a subscription to Pharmacist's Letter, Pharmacy Technician's Letter, and Prescriber Insights: Dual Antiplatelet Therapy for Coronary Artery DiseaseComparison of Oral Beta-BlockersAngiotensin Receptor Blockers and Angiotensin-Converting Enzyme InhibitorsCholesterol Guidelines (United States)Non-Statin Lipid-Lowering AgentsSend us a textIf you're not yet a subscriber, find out more about our product offerings at trchealthcare.com. Follow, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare' or clicking here. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.

John Hertig, PharmD, MS, CPPS, FASHP, is Founder of Hertig Healthcare Advising and former faculty in the Pharmacy Practice Department in the Butler University College of Pharmacy and Health Sciences. He is also Past-President and a current Board of Directors member of the Alliance for Safe Online Pharmacies and is a Member of the United States Food and Drug Administration Drug Safety and Risk Management Advisory Committee. In this episode, he discusses his career, the online pharmacy landscape, the challenges and risks associated with illegal online pharmacies, how athletes and others can help keep themselves safe when accessing medications online, and more.

ASHP's senior education director, Cindy Von Heeringen is joined by John Armitstead, vice president of Pharmacy Services at Lee Health, Jeffrey Reichard, system executive director at UNC Health, and Amy Gutierrez, chief pharmacy officer at John Muir Health, as they discuss their upcoming Midyear session that focuses on applying leadership strategies for system-level pharmacy leaders to generate value within a health system.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Daniel O'Neil, PharmD, MS, FASHP, is the Assistant Vice President of Pharmacy Services at WVU Medicine.We talk through building a technology philosophy for the pharmacy enterprise and you'll hear the direction WVU has taken. You'll also learn pathways and tips to be successful in justifying new technology!

Our guests: "Les Louden, PharmD, MS, Pharmacy Manager St. Joseph's Hospital BayCare Health System, and John B. Hertig, PharmD, MS, CPPS, FASHP, FFIP Founder, Hertig Healthcare Advising, Adjunct Assistant Professor, Purdue University.In this episode, I welcome back Dr. John Hertig along with first-time guest Les Louden from BayCare Health System to discuss their groundbreaking research on controlled substance waste in hospital procedural areas.Their recent study, ""Assessing the Costs of Intravenous Push Waste in Intraoperative Areas Through Observation,"" reveals striking findings about both the financial and operational impact of medication waste. We explore how commonly used medications like fentanyl, hydromorphone, morphine, midazolam, and ketamine are routinely wasted in significant quantities.John and Les discuss how their multi-site study quantified not just product waste but also the substantial ""workforce time waste"" associated with medication disposal processes. With an estimated $56,557 worth of medication and staff time wasted annually at just the hospitals studied, our conversation examines the practical implications for healthcare systems nationwide.We also delve into potential solutions, including automated workflows that significantly reduce documentation time, manufacturer considerations for right-sized medication packaging, and the patient safety implications when clinical staff are pulled away from care to witness waste disposal.Whether you're a healthcare administrator, pharmacy professional, or clinician, this evidence-based discussion offers valuable insights into an often overlooked aspect of healthcare efficiency and resource management.Thanks to our sponsor, MIDAS Healthcare SolutionsLearn more about V.I.E.W. Waste and Return System: https://midashs.com/products/For more information on Drug Diversion mitigation and resources, visit: https://www.rxpert.solutions/

Lisa S. Stump, BSPharm, MS, FASHP, Executive Vice President, Chief Digital Information Officer, and Dean of Information Technology at Mount Sinai Health System, discusses key areas of growth for the year, including advancements in AI and clinical innovation. She addresses anticipated challenges such as the rapid pace of change and transforming operating models, while sharing her strategies for setting the organization up for long-term success.

Lisa S. Stump, BSPharm, MS, FASHP, Executive Vice President, Chief Digital Information Officer, and Dean of Information Technology at Mount Sinai Health System, discusses key areas of growth for the year, including advancements in AI and clinical innovation. She addresses anticipated challenges such as the rapid pace of change and transforming operating models, while sharing her strategies for setting the organization up for long-term success.

It's Best-Of Week on The Academic Minute:  In today's segment, C. Michael White, distinguished professor and chair of pharmacy practice at the University of Connecticut School of Pharmacy, discussed a new treatment for those suffering from depression. Michael White, Pharm.D., FCP, FCCP, FASHP has ~500 publications resulting in 18288 citations with an H-index of 70; […]

Interviews with Leaders in Clinical Pharmacy: Stuart T. Haines, Pharm.D., FCCP, FAPhA, FASHP, BCACP, BCPS, incoming JACCP Editor-in-Chief

Leigh Briscoe-Dwyer, PharmD, BSPharm, BCPS, FASHP, serves as President of the American Society of Health-System Pharmacists (ASHP). She has also served in various organizations and professional societies in New York. We talk through her current presidential year with ASHP and her message of telling your stories that coincides with ASHP's ‘We Are Your Pharmacist' campaign. She is passionate about pharmacy and you'll hear the top issues she is focused on this year!

Explore the essential contributions of health-system pharmacists through engaging interviews with pharmacists and other healthcare team members who witness their impact firsthand. Nearly one in three pharmacists work beyond retail settings, bringing their specialized expertise in medications to hospitals, clinics, and outpatient facilities. As trusted partners on the healthcare team, these pharmacists work to ensure that medications are safe, effective, and accessible, playing a critical role in each patient's journey. Listen in as we uncover the many ways pharmacists make a difference.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Depression sufferers may have a new choice for treatment. C. Michael White, distinguished professor and chair of pharmacy practice at the University of Connecticut School of Pharmacy, explains. Michael White, Pharm.D., FCP, FCCP, FASHP has ~500 publications resulting in 18288 citations with an H-index of 70; placing him within an elite group of researchers. Dr. […]

Special guest Marshall E. Cates, PharmD, BCPP, FASHP, FCCP, FALSHP, Professor of Pharmacy Practice from the McWhorter School of Pharmacy at Samford University joins us to talk about pharmacotherapy for anxiety and depression.Listen in as we discuss pharmacotherapy for managing generalized anxiety disorder and major depression, with a focus on tailoring first- or second-line options to individual patient needs.You'll also hear practical advice from Craig D. Williams, PharmD, FNLA, BCPS, a member of TRC's Editorial Advisory Board and Clinical Professor of Pharmacy Practice at the Oregon Health and Science University.For the purposes of disclosure, Dr. Cates reports relevant financial relationships [psychiatry] with Biogen, Sage Therapeutics (honorarium); Otsuka (speakers bureau).The other speakers have nothing to disclose.  All relevant financial relationships have been mitigated.TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist's Letter or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.The clinical resources mentioned during the podcast are part of a subscription to Pharmacist's Letter and Prescriber Insights: Chart: Pharmacotherapy of Anxiety Disorders in AdultsChart: Choosing and Switching AntidepressantsChart: Combining and Augmenting AntidepressantsIf you're not yet a Pharmacist's Letter or Prescriber Insights subscriber, find out more about our product offerings at trchealthcare.com. Follow or subscribe, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare' or clicking here. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.

Trial of the Week: PROWESS-SHOCK Special Guest: Paul Szumita, PharmD, FCCM, FASHP, BCCCP, BCPS @paulszumita   03:30 – Background studies/Setting the scene 30:25 – PROWESS-SHOCK discussion/Where are we now   Paul Szumita joins to highlight a June Trial of the Week “Drotrecogin alfa (activated) in adults with septic shock” published in the New England Journal of Medicine in 2012. To fully understand the discussion regarding drotrecogin alfa, Paul and I review the mechanism of action and its proposed action in the treatment of sepsis. Then we review earlier studies and the controversy behind the FDA approval process. Finally, we go into detail on what Clinical Pharmacists were tasked with doing at the time based on treatment protocols or hospital restrictions. Then we dive into the Trial of the Week, discussing the study design and results. What was the mood in ICUs and Pharmacy Departments after this publication? How much did our sepsis care improve from PROWESS to PROWESS-SHOCK? What lessons did we learn with the Xigris FDA approval process? Is there a patient population that could still benefit from drotrecogin alfa treatment? Plus, trial fun facts, issues with calculating APACHE II scores, and so much more. Reference list: https://pharmacytodose.com/wp-content/uploads/2024/06/prowess-shock-trial-of-the-week-references.pdf   PharmacyToDose.Com @PharmacyToDose PharmacyToDose@Gmail.com Learn more about your ad choices. Visit megaphone.fm/adchoices

Margins are tight everywhere in healthcare, and a health system pharmacy adds value especially when led by an established chief pharmacy officer.  Jordan Dow, Chief Pharmacy Officer at Froedtert Health, Michael Oinonen, VP of Pharmacy Networks at Vizient, and our usual host Gretchen Brummel, Pharmacy Executive Director for the Vizient Center for Pharmacy Practice Excellence join guest host Carolyn Liptak, Pharmacy Executive Director with the Vizient Center for Pharmacy Practice Excellence to discuss the importance of the CPO role.   Guest speakers:  Jordan Dow, PharmD, MS, FASHP, FACHE Chief Pharmacy Officer Froedtert Health   Michael Oinonen, PharmD VP of Pharmacy Networks  Vizient   Gretchen Brummel, PharmD, BCPS  Pharmacy Executive Director  Vizient Center for Pharmacy Practice Excellence    Host:  Carolyn Liptak, BS Pharmacy, MBA  Pharmacy Executive Director  Vizient Center for Pharmacy Practice Excellence    Show Notes:  [00:54-02:53] Mike Oinonen and Jordon Dow background information  [02:54-04:31] What exactly is a Chief Pharmacy Officer and how the CPO role differs from other types of health system pharmacy leaders [04:32-08:17] Gretchen and Mike discuss their blog post on the CPO role [08:18-07:46] Does the CPO role apply to all health systems in all hospitals big or small [07:47-12:11] How prevalent is this CPO role, and its history [12:12-15:42] Benefits of having a pharmacist at the C-suite level [15:42-19:03] What an organization is mission without a CPO [19:04-21:46] Where the CPO role is going in the future   Links | Resources: A Chief Pharmacy Officer in your C-suite: Vital to health system success  Vizient Pharmacy Solutions  Pharmacy Network  HVPE  ASHP Statement on the Roles and Responsibilities of the Pharmacy Executive  Rationale for having a chief pharmacy officer in a health care organization | American Journal of Health-System Pharmacy | Oxford Academic (oup.com)  The rise of the chief pharmacy officer    Subscribe Today! Apple Podcasts Amazon Podcasts Spotify Android RSS Feed

ACC 2024 Rapid Reaction: Part II Special Guest: Snehal Bhatt, PharmD, BCPS, FASHP, AACC @SnayCardsPharmD   04:05 – EMPACT-MI 29:35 – ULTIMATE-DAPT   Reference List: https://pharmacytodose.files.wordpress.com/2024/05/acc-2024-part-ii-references.pdf   PharmacyToDose.Com @PharmacyToDose PharmacyToDose@Gmail.com Learn more about your ad choices. Visit megaphone.fm/adchoices

Final Four Preview and More: 2024 Critical Care Trials March Madness Bracket   Sepsis/Fluids Bracketologist: Clay Small, PharmD, BCCCP CV/Pulm Bracketologist: Jolie Gallagher, PharmD, BCCCP Bleeding/BG Bracketologist: Jason Hecht, PharmD, BCPS, BCCCP, FCCM Neuro/PADIS Bracketologist: Karen Berger, PharmD, FASHP, FCCM, BCPS, BCCCP   06:10 – Region recaps 32:10 – Final Four preview and predictions 45:30 – Revisiting pre-tournament predictions   PubMed links for all 68 Critical Care March Madness trials: https://pharmacytodose.files.wordpress.com/2024/03/critical-care-trials-reference-list-all-regions.pdf   Listener Bracket: https://pharmacytodose.com/2024/04/01/final-four-2024-critical-care-trials-march-madness-bracket-preview-and-recap/   2024 Critical Care Trials March Madness blank bracket: https://pharmacytodose.com/2024/03/17/2024-critical-care-trials-march-madness-bracket/   PharmacyToDose.Com @PharmacyToDose PharmacyToDose@Gmail.com Learn more about your ad choices. Visit megaphone.fm/adchoices

2024 Critical Care Trials March Madness Bracket Preview: Part I Bleeding/Blood Glucose and Neuro/PADIS Regions   Bleeding/BG Bracketologist: Jason Hecht, PharmD, BCPS, BCCCP, FCCM Neuro/PADIS Bracketologist: Karen Berger, PharmD, FASHP, FCCM, BCPS, BCCCP @karenccrx   PubMed links for all 68 Critical Care March Madness trials: https://pharmacytodose.files.wordpress.com/2024/03/critical-care-trials-reference-list-all-regions.pdf   2024 March Madness Bracket: https://pharmacytodose.com/2024/03/17/2024-critical-care-trials-march-madness-bracket/   PharmacyToDose.Com @PharmacyToDose PharmacyToDose@Gmail.com Learn more about your ad choices. Visit megaphone.fm/adchoices

2024 SCCM Congress: Tuesday Special Guests: Karen Berger, PharmD, FASHP, FCCM, BCCCP, BCPS Melanie Smith Condeni, PharmD, FCCM, BCPS, BCCCP Julie Farrar, PharmD, BCCCP Lama Nazer, PharmD, BCPS Joanna Stollings, PharmD, FCCP, FCCM, BCPS, BCCCP Andy Webb, PharmD, BCCCP 03:05: Star Research Presentation: “Effect of Antipsychotics on Agitation in ICU Delirium: Secondary Analysis of a Randomized Trial” featuring Joanna Stollings 10:43: Star Research Presentations: “Procalcitonin and Antimicrobial Utilization in Critically Ill Cancer Patients with Sepsis (PRO-CAN)” & “Diagnostic and Prognostic Value of Procalcitonin in Critically Ill Cancer Patients with Sepsis” featuring Lama Nazer 25:32: Clinical Pharmacy and Pharmacology (CPP) Year in Review presenter and moderator roundtable discussion featuring Karen Berger, Melanie Smith Condeni, Julie Farrar, and Andy Webb 2024 SCCM Congress website: https://congress2024.sccm.org PharmacyToDose.com  @PharmacyToDose  PharmacyToDose@Gmail.com Learn more about your ad choices. Visit megaphone.fm/adchoices

Interviews with Leaders in Clinical Pharmacy: Leigh Ann Ross, Pharm.D., FCCP, FAPhA, FASHP, FNAP

John Armitstead, MS, RPh, FASHP, is the System Director of Pharmacy Services at Lee Health and a Past President of ASHP. Throughout his career John has been an avid proponent of continuous professional development (CPD). We talk through CPD including goals to set for yourself and how they change overtime as well as some philosophies of practice. This is a great episode to start off the new year as you are planning out new goals!

Jill Bates, PharmD, MS, BCOP, DipACLM, FASHP, is the Deputy Executive Director of the National Pharmacogenomics Program within the National Oncology Program Office of the Veterans Affairs (VA). Dr. Bates is an expert in oncology and pharmacogenomics and has led the VA's Pharmacogenomics program that is being rolled out nationwide. We talk through her background in both areas as well as the  VA's investment in pharmacogenomics and precision medicine. As part of their investment, they are hiring 120 pharmacists in this space across the country. Enjoy all things pharmaocgenomics in this episode! Below are article links of the VA's experience in pharmacogenomics. This article describes the VA's pilot PHASER program: Veterans Affairs Pharmacogenomic Testing for Veterans (PHASER) clinical program - PubMed (nih.gov)This article  reviews the VA's first PDSA cycle on pharmacogenomics implementation: Evaluation of the Veterans Affairs Pharmacogenomic Testing for Veterans (PHASER) clinical program at initial test sites - PubMed (nih.gov)This article talks about the VA NPOP service and the importance of pharmacists within the precision oncology space: Oncology Pharmacists Help Bridge the Gap to Optimize Precision Oncology Services for Veterans With Cancer - PubMed (nih.gov)This article has an overview of the VA's PHASER program and other germline PGx programs throughout North Carolina: North Carolina's multi-institutional pharmacogenomics efforts with the North Carolina Precision Health Collaborative - PubMed (nih.gov)

Intranasal administration of medications is on the rise for both on and off label uses. Dr. Mark Donaldson, Associate Principal and Dr. Philippe Mentler Senior Consulting Director, both at Vizient join host Gretchen Brummel for two episodes, sharing details on these drugs, their actions and indications.   Guest speakers: Mark Donaldson, BSP, RPH, PHARMD, FASHP, FACHE Associate Principal Vizient Philippe Mentler, PHARMD, BCPS Senior Consulting Director Vizient Moderator: Gretchen Brummel, PharmD, BCPS Pharmacy Executive Director Vizient Center for Pharmacy Practice Excellence   Show Notes: [00:33 - 02:50] Why you would choose intra-nasal administration of an agent over some of the other non-oral or non-IV routes [02:51 - 6:05] Some practical considerations people should be aware of, particularly when not to use these agents [6:06 - 7:12] Some of the implications for the pediatric population [7:13 - 12:10] What we have to look forward to in the future in this space [12:11 - 13:46] What our frontline pharmacy staff should know about these medications   Subscribe Today! Apple Podcasts Amazon Podcasts Google Podcasts Spotify Android RSS Feed  

Intranasal administration of medications is on the rise for both on and off label uses. Dr. Mark Donaldson, Associate Principal and Dr. Phillipe Mentler Senior Consulting Director, both at Vizient join host Gretchen Brummel for two episodes, sharing details on these drugs, their actions and indications.   Guest speakers: Mark Donaldson, BSP, RPH, PHARMD, FASHP, FACHE Associate Principal Vizient Phillipe Mentler, PHARMD, BCPS Senior Consulting Director Vizient Moderator: Gretchen Brummel, PharmD, BCPS Pharmacy Executive Director Vizient Center for Pharmacy Practice Excellence   Show Notes: [01:16 - 03:46] Why the nose is a good target for medication administration [03:47 - 5:49] Some things you need to consider when administering medications intra-nasally [5:50 - 8:13] Some of the labeled and off-label intra-nasal medications and their indications [8:14 - 9:15] What we should be thinking about in terms of safety [9:16 - 10:06] Wrong route, have you seen that in your practice, or have there been reports of that in the literature [10:07 - 15:10] How some of these drugs are used in dental medicine   Subscribe Today! Apple Podcasts Amazon Podcasts Google Podcasts Spotify Android RSS Feed

Nish Kasbekar, PharmD, BSPharm, FASHP, is the President of the American Society of Health System Pharmacists (ASHP) and Chief Pharmacy Officer at the University of Pennsylvania Health System.Dr. Kasbekar talks through her priorities for ASHP this year, her path through professional organizations and her advice to those looking to get involved! Read the article from The Philadelphia Inquirer where they covered what an ICU Pharmacist does as Nish describes in the episode! More pharmacists should be in the news highlighting the great work they do everyday!

CancerNetwork® spoke with experts across multiple disciplines about the far-reaching impacts of the ongoing shortages of chemotherapy drugs including carboplatin and cisplatin, and how practices may be able to mitigate these challenges in the short and long term.  Michael Ganio, PharmD, MS, BCPS, FASHP, described the causes of carboplatin and cisplatin being in short supply across the United States and how the FDA is working with Chinese manufacturers to import these chemotherapy agents. Ganio, senior director of Pharmacy Practice and Quality at the American Society of Health-System Pharmacists, stated that communication is paramount among all members of a care team to help prevent critical errors while treating patients with limited supplies of these drugs. He also spoke about how reaching out to local representatives may help address the issues resulting from these shortages. “Advocacy is needed,” Ganio said. “Our policymakers need to know that these shortages are having a real-world impact, and that they need to be addressed.” Brian Slomovitz, MD, MS, FACOG, spoke about how he is managing the ongoing shortages in the context of his gynecologic cancer care, including swapping one platinum-based drug for another during treatment. Slomovitz, a gynecologic oncologist, director of Gynecologic Oncology, and co-chair of the Cancer Research Committee at Mount Sinai Medical Center in Miami Beach, Florida and a professor of Obstetrics and Gynecology at Florida International University, also described the challenges many practices across the country have due to lacking platinum-based drugs altogether. “I know there are institutions that don't have [platinum-based chemotherapy],” Slomovitz said. “There are institutions that aren't able to give their patients the best standard-of-care therapy and aren't able to enroll patients in trials because of lack of therapy.”  Lucio N. Gordan, MD, addressed the financial impacts of these shortages, discussing how his practice has managed the rising prices of carboplatin and cisplatin in the country. Gordan, president and managing physician at Florida Cancer Specialists & Research Institute who sees patients in the state-wide practice's Gainesville Cancer Center, stated that efforts from major oncology organizations may help increase adequate access to chemotherapy drugs. “It's very important that the large practices and institutions in the country stay united,” Gordan said. “The Community Oncology Alliance [COA], American Society of Clinical Oncology [ASCO], and others are trying to push legislation that would protect the consumer, the patients, and us to make sure that we have a proven supply.” Don't forget to subscribe to the “Oncology On-The-Go” podcast on Apple Podcasts, Spotify, or anywhere podcasts are available.

On episode 35 with Dr. Megan Rech we dove into the reasons why clinical pharmacists are leaving health systems and on episode 53 with Dr. Alicia Lichvar we talked about the pressures on clinical pharmacists. This week I sat down with Dr. Bryan McCarthy Jr, System Director of Inpatient Pharmacy at Lifespan, to talk through how they are addressing the need for clinical pharmacist retention through a change in their practice model by including remote clinical pharmacists. You'll hear how the model works and how it's impacted their retention!

Dr. Rob T. Adamson PharmD, FASHP, Executive Vice President & Chief Information Officer and Operational Leader for the Epic Electronic Health Record implementation at RWJBaranas Health discusses delegation and employee when converting to Epic.

Presentations are a topic we are all familiar with and strive to improve upon. Whether it is for a discussion with your team and you are pitching an idea for a protocol or you are presenting at a national meeting, you want to be able to tell the story in a way that connects to the audience. We talk about ways to become a more effective presenter in this episode!Dave Hager, PharmD, BCPS, FASHP, is the Senior Director at Visante. He previously served as Director of Clinical Services at UW Health in Madison, WI. Dr. Hager is a frequent national and regional speaker. We talk through his four tips to a successful presentation and how to make your presentations more effective. There are so many good parts to this episode that it is one you can come back to time and time again!

Is there a better way to treat anxiety and depression for patients with cancer? C. Michael White, distinguished professor and chair of pharmacy practice at the University of Connecticut School of Pharmacy, considers the question. Michael White, Pharm.D., FCP, FCCP, FASHP has ~500 publications resulting in 16577 citations with an H-index of 67; placing him […]

In this podcast, Jeannell Mansur, R.Ph., Pharm.D., FASHP, FSMSO, CJCP, Principal Consultant for Medication Management and Safety with Joint Commission Resources will discuss the scope and significant changes to the revised USP Chapter and how it relates to the go-live for USP Chapter . Dr. Mansur will also provide recommendations for how hospitals can assess their compliance with these new requirements, as well as how the Joint Commission survey process will address these new requirements.This episode is sponsored by Joint Commission Resources.The use of Joint Commission Resources consultative technical or advisory services is not necessary to obtain a Joint Commission Accreditation award, nor does it influence the granting of such awards.

In this podcast, Jeannell Mansur, R.Ph., Pharm.D., FASHP, FSMSO, CJCP, Principal Consultant for Medication Management and Safety with Joint Commission Resources will discuss the scope and significant changes to the revised USP Chapter and how it relates to the go-live for USP Chapter . Dr. Mansur will also provide recommendations for how hospitals can assess their compliance with these new requirements, as well as how the Joint Commission survey process will address these new requirements.This episode is sponsored by Joint Commission Resources.

Benjamin J. Anderson, PharmD, MPH, FASHP and Diana J. Schreier, PharmD, MBA, BCPS recognize the history and regulations for prospective medication order review, describe the technical landscape for verification decision support and explore real-world verification decision support outcomes. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter! You can also connect with the Mayo Clinic's School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

This week we sit down with Alison Gulbis, PharmD, BCOP, Kamakshi Rao, PharmD, BCOP, FASHP, and Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA to discuss their work on the Oncology Workforce Collaborative. Alison is a Clinical Pharmacy Manager at the University of Texas MD Anderson Cancer Center in Houston, TX. She obtained her PharmD at the University of Florida and completed her PGY1 and PGY2 residencies at the Medical University of South Carolina. She has been in clinical practice for 19 years at MD Anderson and manages a team of clinical pharmacy specialists in pediatric hematology/oncology and adult stem cell transplant.Kamakshi is an Interim Director of Pharmacy at the University of North Carolina Medical Center in Chapel Hill. She oversees Adult Ambulatory and Acute Clinical Services as well as the hospital's academic enterprises, including resident and student training programs.  Additionally, she leads the department's growing efforts around diversity, equity, and inclusion. She spent 20 years in direct patient care, working with patients undergoing bone marrow transplants at the North Carolina Cancer Hospital before moving into her current role.Zahra is a Clinical Pharmacy Manager in the Division of Hematologic Malignancies and Cellular Therapeutics at the University of Kansas Health System (TUKHS). She earned her PharmD and MBA from the UMKC School of Pharmacy and the Henry W. Bloch School of Management. She completed residency training at The Ohio State University Medical Center and The Huntsman Cancer Institute at the University of Utah. She has been a board-certified oncology pharmacist since 2012. In 2022, she was the recipient of the ASTCT Pharmacy Special Interest Group Lifetime Achievement Award and ASCO's 40 Under 40 in Cancer award.You can read more here: https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/jac5.1693

Paul Walker, PharmD, FASHP,  is the current President of the American Society of Health System Pharmacists (ASHP) and is a Clinical Professor and Assistant Dean of experiential education and community engagement at the University of Michigan College of Pharmacy and Manager in the Department of Pharmacy at Michigan Medicine. Dr. Walker describes his impactful year as President of ASHP as his theme of “Better Together” has resonated amongst the pharmacy community. He also talks through the next steps of ASHP's Task Force on DEI and the impact that having diverse representation in professional organizations has on our profession!

Julie L. Cunningham, PharmD, BCPP; M. Zeeshan Rizwan, PharmD, BCPS, BCCCP; Christi A. Jen, PharmD, BCPS, FASHP, FAzPA; and Kristina L. Wescott, PharmD, BCPS identify appropriate non-stigmatizing language related to opioids and addiction in the context of patient care discussions, discuss risks for opioid harms related to individual risks at points of transitions of patient care, review interventions for high-risk opioid patients across transitions of care and identify resources in multiple areas of practice to support patient care for opioid use. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter! You can also connect with the Mayo Clinic's School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.